NAD IV therapy: separating real science from the hype

What did @drvinodchopra actually say?

A plastic surgeon paid $1,100 for a four-hour NAD+ IV infusion and reported feeling "really really good" the next day, with less neck and joint pain. He described NAD as "a coenzyme in ourselves" that acts as "an electron carrier" for oxidation-reduction reactions, and framed it as "the new anti-aging thing." He also mentioned hoping for "improvement in hair growth" but stopped short of making hard promises.

Credit where it's due: he disclosed the cost, the side effects he experienced (nausea and chest tightness when the drip ran too fast), and he hedged appropriately by saying "we'll see" about long-term benefits. That's more honest than most NAD IV content on TikTok, where the claims tend to run much hotter.

Does the science back this up?

The biochemistry is real. The clinical evidence for IV NAD+ in healthy adults is thin. NAD+ is a legitimate coenzyme central to cellular energy metabolism and DNA repair, and levels do decline with age. That part is well-established. What's not established is whether infusing it intravenously in a healthy person produces meaningful anti-aging effects.

Most human NAD+ research involves precursor supplementation (NMN or NR taken orally), not IV delivery, and even that evidence is preliminary. A 2023 randomized trial by Liao et al. in Nature Aging found NMN supplementation improved muscle insulin sensitivity in older adults, but that's not the same as IV NAD+ in a 40-something surgeon. A 2022 review by Mehmel et al. in Nutrients noted that while animal models show promising results, human clinical data remains sparse. The nausea and chest tightness he described are well-documented adverse effects of IV NAD+ running too quickly, suggesting the dose-delivery relationship matters more than clinics often admit.

What did they get wrong (or right)?

The biochemistry explanation is accurate but incomplete. Calling NAD a coenzyme involved in oxidation-reduction reactions is correct. Calling it "an electron carrier" is a reasonable simplification. What he skips is that most of the excitement around NAD+ involves its role as a substrate for sirtuins and PARP enzymes involved in DNA repair, not just redox reactions. That omission matters because it's the sirtuin pathway that drives most of the anti-aging hypothesis.

The claim that he felt better the next day is anecdote, not evidence. Post-infusion wellness is a known placebo-adjacent effect, and it's not a reliable signal of cellular change. The hair growth comment has essentially no clinical backing for IV NAD+ specifically. There are no published trials showing IV NAD+ promotes hair growth in humans. That one should have come with a bigger caveat than it did.

• Accurate: NAD+ biochemistry basics
• Accurate: disclosed side effects and cost
• Unverifiable: next-day pain relief from a single session
• Misleading by omission: hair growth claim lacks any trial support

What should you actually know?

IV NAD+ therapy is not FDA-approved for anti-aging, and there are no large-scale, placebo-controlled trials confirming it works for the outcomes being sold, including pain relief, energy, or hair growth. Clinics charging $1,100 per session are operating in a largely evidence-free commercial space, even if the underlying biology is interesting.

The side effects he described, nausea and chest tightness, are real and documented. A 2021 case series by Braidy et al. in Antioxidants noted that infusion rate directly correlates with adverse events. Slower infusion reduces symptoms, but it also means you're spending four hours in a chair for benefits that haven't been proven in a rigorous trial.

If you're interested in NAD+ biology, the more evidence-supported route right now is oral NR or NMN supplementation, where at least a handful of human trials exist. That's not a recommendation to take them. It's a note that the IV route is the least-studied delivery method, not the most advanced one, which is how it tends to get marketed.